| __timestamp | Teva Pharmaceutical Industries Limited | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 20272000000 | 28796000 |
| Thursday, January 1, 2015 | 19652000000 | 51168000 |
| Friday, January 1, 2016 | 21903000000 | 54383000 |
| Sunday, January 1, 2017 | 22385000000 | 63924000 |
| Monday, January 1, 2018 | 18854000000 | 90857000 |
| Tuesday, January 1, 2019 | 16887000000 | 117850000 |
| Wednesday, January 1, 2020 | 16658000000 | 124179000 |
| Friday, January 1, 2021 | 15878000000 | 156184000 |
| Saturday, January 1, 2022 | 14925000000 | 164365000 |
| Sunday, January 1, 2023 | 15846000000 | 197516000 |
| Monday, January 1, 2024 | 16544000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, Teva Pharmaceutical Industries Limited and Vericel Corporation present a fascinating study in contrasts. Over the past decade, Teva's annual revenue has seen a decline of approximately 22%, from its peak in 2017 to 2023. Meanwhile, Vericel has experienced a remarkable growth trajectory, with its revenue increasing nearly sevenfold during the same period.
Teva, a global leader in generic medicines, faced challenges that led to a revenue dip from 2017's high of $22 billion to around $15.8 billion in 2023. This decline reflects broader industry trends and internal restructuring efforts.
Conversely, Vericel, specializing in advanced cell therapies, has capitalized on niche markets, growing its revenue from $28 million in 2014 to nearly $198 million in 2023. This growth underscores the potential of innovative therapies in the pharmaceutical sector.
Eli Lilly and Company or Vericel Corporation: Who Leads in Yearly Revenue?
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Examining Key Revenue Metrics
AstraZeneca PLC and Vericel Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: Novartis AG vs Teva Pharmaceutical Industries Limited
Revenue Insights: Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited Performance Compared
Vertex Pharmaceuticals Incorporated vs Vericel Corporation: Annual Revenue Growth Compared
Revenue Insights: GSK plc and Vericel Corporation Performance Compared
Revenue Insights: Teva Pharmaceutical Industries Limited and United Therapeutics Corporation Performance Compared
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs ADMA Biologics, Inc.
Comparing Revenue Performance: Teva Pharmaceutical Industries Limited or Celldex Therapeutics, Inc.?
Catalent, Inc. vs Vericel Corporation: Examining Key Revenue Metrics
Telix Pharmaceuticals Limited and Vericel Corporation: A Comprehensive Revenue Analysis